KNG1
Kininogen-1
Also known as: BDK, BK, HK, HMWK, KNG, KNG1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01042
- Gene
- KNG1
- Ensembl
- ENSG00000113889
- Chromosome
- 3
- Canonical length
- 644 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene uses alternative splicing to generate two different proteins- high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK). HMWK is essential for blood coagulation and assembly of the kallikrein-kinin system. Also, bradykinin, a peptide causing numerous physiological effects, is released from HMWK. Bradykinin also functions as an antimicrobial peptide with antibacterial and antifungal activity. In contrast to HMWK, LMWK is not involved in blood coagulation. Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reduces or depletes angiotensin converting enzyme 2 (ACE2), which results in an increase in levels of des-Arg(9)-bradykinin, a bioactive metabolite of bradykinin that is associated with lung injury and inflammation. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2020]
Canonical amino-acid sequenceUniProt
644 residues, UniProt reviewed canonical sequence.
>P01042|KNG1
1 MKLITILFLC SRLLLSLTQE SQSEEIDCND KDLFKAVDAA LKKYNSQNQS NNQFVLYRIT
61 EATKTVGSDT FYSFKYEIKE GDCPVQSGKT WQDCEYKDAA KAATGECTAT VGKRSSTKFS
121 VATQTCQITP AEGPVVTAQY DCLGCVHPIS TQSPDLEPIL RHGIQYFNNN TQHSSLFMLN
181 EVKRAQRQVV AGLNFRITYS IVQTNCSKEN FLFLTPDCKS LWNGDTGECT DNAYIDIQLR
241 IASFSQNCDI YPGKDFVQPP TKICVGCPRD IPTNSPELEE TLTHTITKLN AENNATFYFK
301 IDNVKKARVQ VVAGKKYFID FVARETTCSK ESNEELTESC ETKKLGQSLD CNAEVYVVPW
361 EKKIYPTVNC QPLGMISLMK RPPGFSPFRS SRIGEIKEET TVSPPHTSMA PAQDEERDSG
421 KEQGHTRRHD WGHEKQRKHN LGHGHKHERD QGHGHQRGHG LGHGHEQQHG LGHGHKFKLD
481 DDLEHQGGHV LDHGHKHKHG HGHGKHKNKG KKNGKHNGWK TEHLASSSED STTPSAQTQE
541 KTEGPTPIPS LAKPGVTVTF SDFQDSDLIA TMMPPISPAP IQSDDDWIPD IQIDPNGLSF
601 NPISDFPDTT SPKCPGRPWK SVSEINPTTQ MKESYYFDLT DGLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KNG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 2,986 nTPM
Expression across tissuesHPA
Tissue
- liver: 2,986 nTPM
- kidney: 433 nTPM
- rectum: 0.9 nTPM
- colon: 0.8 nTPM
- cerebral cortex: 0.4 nTPM
- placenta: 0.4 nTPM
Single-cell type
- hepatocytes: 2,201 nCPM
- distal convoluted tubule cells: 648 nCPM
- loop of henle epithelial cells: 131 nCPM
- renal connecting tubule cells: 108 nCPM
- cholangiocytes: 36 nCPM
- kupffer cells: 25 nCPM
Immune cell
- basophil: 0.4 nTPM
- neutrophil: 0.2 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 1 nTPM
- cerebellum: 0.5 nTPM
- white matter: 0.5 nTPM
- basal ganglia: 0.4 nTPM
- medulla oblongata: 0.4 nTPM
- midbrain: 0.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KNG1.
Disease | AllUniProt
Conditions KNG1 is implicated in, by any mechanism.
- High molecular weight kininogen deficiency (HMWK deficiency) MIM:228960
- Angioedema, hereditary, 6 (HAE6) MIM:619363
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 149 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- High molecular weight kininogen deficiency
- Angioedema, hereditary, 6
- KININOGEN DEFICIENCY, TOTAL
Disease | ImmuneIEDB
Conditions an epitope on KNG1 was assayed in.
- rheumatoid arthritis B cell
- sarcoidosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.11
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood coagulation
- inflammatory response
- negative regulation of blood coagulation
- negative regulation of cell adhesion
- negative regulation of proteolysis
- positive regulation of apoptotic process
- positive regulation of cytosolic calcium ion concentration
- vasodilation
Molecular functions
- cysteine-type endopeptidase inhibitor activity
- heparin binding
- hormone activity
- signaling receptor binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cystatin domain
- Proteinase inhibitor I25, cystatin, conserved site
- Cystatin superfamily
- Kininogen/Fetuin/Histidine-rich Glycoprotein
- Cystatin domain
- HMW kininogen
- Kininogen-type cystatin domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KNG1 as an antibody target. Whether an autoantibody or antibody against KNG1 could matter depends on whether native KNG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KNG1 is annotated as secreted, so native KNG1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label KNG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...